Constellium Q2 2024 GAAP EPS $0.52 Beats $0.42 Estimate, Sales $1.933B Beat $1.886B Estimate
Portfolio Pulse from Benzinga Newsdesk
Constellium (NYSE:CSTM) reported Q2 2024 GAAP EPS of $0.52, beating the $0.42 estimate by 23.1%. Sales were $1.933 billion, surpassing the $1.886 billion estimate by 2.51%, despite a 9.04% decrease from the same period last year.
July 23, 2024 | 10:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Constellium (NYSE:CSTM) reported Q2 2024 GAAP EPS of $0.52, beating the $0.42 estimate by 23.1%. Sales were $1.933 billion, surpassing the $1.886 billion estimate by 2.51%, despite a 9.04% decrease from the same period last year.
Constellium's better-than-expected earnings and sales figures are likely to positively impact its stock price in the short term. Beating both EPS and sales estimates typically boosts investor confidence, despite the year-over-year sales decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100